The Endoscopy Market was valued at USD 42.4 billion in 2024, and is projected to reach USD 118.7 billion by 2034, rising at a CAGR of 11.3%. This expansion is driven by rapid advancements in medical imaging, improved reimbursement frameworks, a rising prevalence of chronic diseases, and an increasing demand for cost-effective diagnostic solutions. Endoscopic technology has evolved significantly with innovations like high-definition (HD) imaging, 3D visualization, and Narrow-Band Imaging (NBI), enhancing diagnostic accuracy. The integration of robotics, artificial intelligence (AI), and wireless communication further improves procedural efficiency. Additionally, the adoption of lightweight, flexible, and single-use endoscopes reduces infection risks while improving accessibility and affordability. The growing need for minimally invasive techniques across multiple medical fields has solidified endoscopy as a preferred diagnostic and treatment method.
The product landscape includes endoscopes, visualization systems, endoscopic ultrasound, insufflators, and other devices. Endoscopes dominated the market, generating USD 21.5 billion in 2024. On the application front, the market spans laparoscopy, gastrointestinal (GI) endoscopy, arthroscopy, ENT endoscopy, pulmonary endoscopy, obstetrics/gynecology, and other procedures. Laparoscopy accounted for USD 11.2 billion in 2024, expanding at an 11.5% CAGR through 2034. The rising preference for minimally invasive surgeries has fueled this segment, as procedures performed through small incisions reduce recovery time and postoperative complications. Demand for laparoscopic surgeries is accelerating, particularly for gallbladder removal, hernia repair, and bariatric procedures. With obesity on the rise, more individuals are opting for weight-loss surgeries, further propelling market growth. The increasing availability of laparoscopic training programs ensures more surgeons can adopt these techniques, promoting wider adoption.
Hospitals remain the largest end-user segment, with projections indicating a market value of USD 61 billion by 2034. Healthcare institutions rely on endoscopy for routine screenings, early disease detection, and surgical interventions, particularly in oncology. Favorable reimbursement policies and insurance coverage for endoscopic procedures encourage hospitals to invest in advanced equipment and training programs. By expanding their endoscopic capabilities, hospitals improve patient outcomes while optimizing healthcare costs. The demand for high-quality, cost-effective procedures continues to drive technological advancements and infrastructure investments in healthcare facilities.
North America holds a significant share of the market, with the US leading at USD 16.5 billion in 2024. The rising burden of chronic diseases, particularly gastrointestinal disorders and obesity, has heightened the demand for endoscopic procedures. The presence of advanced healthcare infrastructure and ongoing technological innovations, such as AI-assisted endoscopy and robotic systems, strengthens market expansion. Additionally, reimbursement policies supporting diagnostic and therapeutic endoscopic procedures have improved patient access, further fueling demand. The continued emphasis on early disease detection and preventive healthcare solidifies the region’s dominance in the global endoscopy market.
This product will be delivered within 2-4 business days.
The product landscape includes endoscopes, visualization systems, endoscopic ultrasound, insufflators, and other devices. Endoscopes dominated the market, generating USD 21.5 billion in 2024. On the application front, the market spans laparoscopy, gastrointestinal (GI) endoscopy, arthroscopy, ENT endoscopy, pulmonary endoscopy, obstetrics/gynecology, and other procedures. Laparoscopy accounted for USD 11.2 billion in 2024, expanding at an 11.5% CAGR through 2034. The rising preference for minimally invasive surgeries has fueled this segment, as procedures performed through small incisions reduce recovery time and postoperative complications. Demand for laparoscopic surgeries is accelerating, particularly for gallbladder removal, hernia repair, and bariatric procedures. With obesity on the rise, more individuals are opting for weight-loss surgeries, further propelling market growth. The increasing availability of laparoscopic training programs ensures more surgeons can adopt these techniques, promoting wider adoption.
Hospitals remain the largest end-user segment, with projections indicating a market value of USD 61 billion by 2034. Healthcare institutions rely on endoscopy for routine screenings, early disease detection, and surgical interventions, particularly in oncology. Favorable reimbursement policies and insurance coverage for endoscopic procedures encourage hospitals to invest in advanced equipment and training programs. By expanding their endoscopic capabilities, hospitals improve patient outcomes while optimizing healthcare costs. The demand for high-quality, cost-effective procedures continues to drive technological advancements and infrastructure investments in healthcare facilities.
North America holds a significant share of the market, with the US leading at USD 16.5 billion in 2024. The rising burden of chronic diseases, particularly gastrointestinal disorders and obesity, has heightened the demand for endoscopic procedures. The presence of advanced healthcare infrastructure and ongoing technological innovations, such as AI-assisted endoscopy and robotic systems, strengthens market expansion. Additionally, reimbursement policies supporting diagnostic and therapeutic endoscopic procedures have improved patient access, further fueling demand. The continued emphasis on early disease detection and preventive healthcare solidifies the region’s dominance in the global endoscopy market.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2024
Chapter 5 Market Estimates and Forecast, by Product, 2021-2034 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Application, 2021-2034 ($ Mn)
Chapter 7 Market Estimates and Forecast, by End Use, 2021-2034 ($ Mn)
Chapter 8 Market Estimates and Forecast, by Region, 2021-2034 ($ Mn)
Chapter 9 Company Profiles
Companies Mentioned
The companies featured in this Endoscopy market report include:- B Braun
- Boston Scientific
- CONMED
- COOK MEDICAL
- FUJIFILM
- HOYA
- INTUITIVE
- Johnson & Johnson
- KARL STORZ
- Medtronic
- OLYMPUS
- RICHARD WOLF
- Smith & Nephew
- Stryker
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 140 |
Published | February 2025 |
Forecast Period | 2024 - 2034 |
Estimated Market Value ( USD | $ 42.4 Billion |
Forecasted Market Value ( USD | $ 118.7 Billion |
Compound Annual Growth Rate | 11.3% |
Regions Covered | Global |
No. of Companies Mentioned | 15 |